Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | JNJ-87704916 |
Trade Name | |
Synonyms | JNJ87704916|JNJ 87704916 |
Drug Descriptions |
JNJ-87704916 is a recombinant oncolytic herpes simplex virus type 1 (HSV-1), which potentially induces tumor cell lysis and an antitumor immune response (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C205181 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Cetrelimab + JNJ-87704916 | Cetrelimab JNJ-87704916 | 0 | 1 |
JNJ-87704916 | JNJ-87704916 | 0 | 1 |